NO20005732D0 - Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer - Google Patents
Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorerInfo
- Publication number
- NO20005732D0 NO20005732D0 NO20005732A NO20005732A NO20005732D0 NO 20005732 D0 NO20005732 D0 NO 20005732D0 NO 20005732 A NO20005732 A NO 20005732A NO 20005732 A NO20005732 A NO 20005732A NO 20005732 D0 NO20005732 D0 NO 20005732D0
- Authority
- NO
- Norway
- Prior art keywords
- phenylethylamines
- phenylsulfonamide
- useful
- dopamine receptors
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8549398P | 1998-05-14 | 1998-05-14 | |
| PCT/US1999/007023 WO1999058499A1 (en) | 1998-05-14 | 1999-05-07 | Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005732L NO20005732L (no) | 2000-11-13 |
| NO20005732D0 true NO20005732D0 (no) | 2000-11-13 |
Family
ID=22191975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005732A NO20005732D0 (no) | 1998-05-14 | 2000-11-13 | Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6103766A (enExample) |
| EP (1) | EP1077935B1 (enExample) |
| JP (1) | JP2002514623A (enExample) |
| KR (1) | KR20010043546A (enExample) |
| CN (1) | CN1152857C (enExample) |
| AT (1) | ATE253045T1 (enExample) |
| AU (1) | AU752543B2 (enExample) |
| BR (1) | BR9910405A (enExample) |
| CA (1) | CA2327345A1 (enExample) |
| DE (1) | DE69912419T2 (enExample) |
| DK (1) | DK1077935T3 (enExample) |
| EA (1) | EA002918B1 (enExample) |
| ES (1) | ES2211078T3 (enExample) |
| HU (1) | HUP0101746A3 (enExample) |
| IL (1) | IL139263A0 (enExample) |
| NO (1) | NO20005732D0 (enExample) |
| NZ (1) | NZ508152A (enExample) |
| PL (1) | PL343891A1 (enExample) |
| PT (1) | PT1077935E (enExample) |
| SK (1) | SK16242000A3 (enExample) |
| TR (1) | TR200003325T2 (enExample) |
| TW (1) | TW450954B (enExample) |
| WO (1) | WO1999058499A1 (enExample) |
| ZA (1) | ZA200005921B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT971878E (pt) * | 1997-02-27 | 2008-07-08 | Takeda Pharmaceutical | Compostos de amina, sua produção e utilização como inibidores da produção de amilóide beta |
| JP2005508852A (ja) * | 2001-05-07 | 2005-04-07 | スミスクライン・ビーチャム・コーポレイション | スルホンアミド |
| WO2002089785A1 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
| ATE520659T1 (de) | 2004-10-14 | 2011-09-15 | Abbott Gmbh & Co Kg | Zur behandlung von auf die modulation des dopamin-d3-rezeptors ansprechenden erkrankungen geeignete azabicycloheptylverbindungen |
| CA2583918C (en) * | 2004-10-14 | 2013-01-29 | Abbott Gmbh & Co. Kg | Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| DE602005027382D1 (de) | 2004-10-14 | 2011-05-19 | Abbott Gmbh & Co Kg | Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete heterocyclische verbindungen |
| TWI400233B (zh) * | 2006-04-14 | 2013-07-01 | Abbott Gmbh & Co Kg | 適用於治療對多巴胺ｄ3受體之調節有反應的疾病之芳氧基乙胺化合物 |
| CA2648543C (en) * | 2006-04-14 | 2015-06-02 | Abbott Gmbh & Co. Kg | Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| JP2009534355A (ja) | 2006-04-19 | 2009-09-24 | アボット ゲーエムベーハー ウント カンパニー カーゲー | セロトニン５ｈｔ６受容体の調節に応答する障害を治療するために好適な複素環化合物 |
| MX2008013434A (es) | 2006-04-19 | 2009-01-26 | Abbott Gmbh & Co Kg | Arilsufonas heterociclicas adecuadas para tratar trastornos que responden a la modulacion del receptor de serotonina 5ht6. |
| WO2008026046A1 (en) * | 2006-08-30 | 2008-03-06 | Pfizer Products Inc. | Morpholine d3 dopamine antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3574741A (en) * | 1969-04-14 | 1971-04-13 | Mead Johnson & Co | Sulfonamidophenalkylamines |
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| GB9402197D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Compounds |
| CN1088062C (zh) * | 1994-11-23 | 2002-07-24 | 纽罗根公司 | 某些4－氨基甲基－2－取代的咪唑衍生物2－氨基甲基－4－取代的咪唑衍生物新的一族多巴胺受体亚型特异性配体 |
| EP0917530B1 (en) * | 1996-05-11 | 2003-02-19 | SmithKline Beecham plc | Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| US5922770A (en) * | 1996-07-22 | 1999-07-13 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| JPH1180156A (ja) * | 1997-09-04 | 1999-03-26 | Hokuriku Seiyaku Co Ltd | １−（置換アリール）アルキル−１ｈ−イミダゾピリジン−４−アミン誘導体 |
-
1999
- 1999-04-26 TW TW088106644A patent/TW450954B/zh not_active IP Right Cessation
- 1999-05-07 US US09/306,748 patent/US6103766A/en not_active Expired - Fee Related
- 1999-05-07 CN CNB998052175A patent/CN1152857C/zh not_active Expired - Fee Related
- 1999-05-07 AT AT99919771T patent/ATE253045T1/de not_active IP Right Cessation
- 1999-05-07 IL IL13926399A patent/IL139263A0/xx not_active IP Right Cessation
- 1999-05-07 WO PCT/US1999/007023 patent/WO1999058499A1/en not_active Ceased
- 1999-05-07 AU AU37418/99A patent/AU752543B2/en not_active Ceased
- 1999-05-07 JP JP2000548303A patent/JP2002514623A/ja not_active Withdrawn
- 1999-05-07 NZ NZ508152A patent/NZ508152A/xx unknown
- 1999-05-07 KR KR1020007012661A patent/KR20010043546A/ko not_active Abandoned
- 1999-05-07 DK DK99919771T patent/DK1077935T3/da active
- 1999-05-07 SK SK1624-2000A patent/SK16242000A3/sk unknown
- 1999-05-07 PL PL99343891A patent/PL343891A1/xx unknown
- 1999-05-07 DE DE69912419T patent/DE69912419T2/de not_active Expired - Fee Related
- 1999-05-07 BR BR9910405-9A patent/BR9910405A/pt not_active Application Discontinuation
- 1999-05-07 EP EP99919771A patent/EP1077935B1/en not_active Expired - Lifetime
- 1999-05-07 CA CA002327345A patent/CA2327345A1/en not_active Abandoned
- 1999-05-07 ES ES99919771T patent/ES2211078T3/es not_active Expired - Lifetime
- 1999-05-07 HU HU0101746A patent/HUP0101746A3/hu unknown
- 1999-05-07 PT PT99919771T patent/PT1077935E/pt unknown
- 1999-05-07 TR TR2000/03325T patent/TR200003325T2/xx unknown
- 1999-05-07 EA EA200001184A patent/EA002918B1/ru not_active IP Right Cessation
-
2000
- 2000-10-23 ZA ZA200005921A patent/ZA200005921B/en unknown
- 2000-11-13 NO NO20005732A patent/NO20005732D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0101746A2 (hu) | 2002-03-28 |
| NZ508152A (en) | 2003-03-28 |
| TW450954B (en) | 2001-08-21 |
| PT1077935E (pt) | 2004-03-31 |
| SK16242000A3 (sk) | 2001-06-11 |
| AU752543B2 (en) | 2002-09-19 |
| NO20005732L (no) | 2000-11-13 |
| WO1999058499A1 (en) | 1999-11-18 |
| TR200003325T2 (tr) | 2001-04-20 |
| DE69912419D1 (de) | 2003-12-04 |
| PL343891A1 (en) | 2001-09-10 |
| EA200001184A1 (ru) | 2001-04-23 |
| EP1077935A1 (en) | 2001-02-28 |
| KR20010043546A (ko) | 2001-05-25 |
| BR9910405A (pt) | 2001-01-09 |
| ES2211078T3 (es) | 2004-07-01 |
| EA002918B1 (ru) | 2002-10-31 |
| JP2002514623A (ja) | 2002-05-21 |
| IL139263A0 (en) | 2001-11-25 |
| HUP0101746A3 (en) | 2002-10-28 |
| CN1297431A (zh) | 2001-05-30 |
| EP1077935B1 (en) | 2003-10-29 |
| US6103766A (en) | 2000-08-15 |
| ZA200005921B (en) | 2001-11-14 |
| HK1036049A1 (en) | 2001-12-21 |
| ATE253045T1 (de) | 2003-11-15 |
| DK1077935T3 (da) | 2004-02-16 |
| DE69912419T2 (de) | 2004-07-22 |
| CA2327345A1 (en) | 1999-11-18 |
| CN1152857C (zh) | 2004-06-09 |
| AU3741899A (en) | 1999-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005732D0 (no) | Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer | |
| DK0923542T3 (da) | Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander | |
| NO973532L (no) | 2-aminoindaner som selektive dopamin D3-ligander | |
| BR0014733A (pt) | Derivados éter biarìlico úteis como inibidores de recaptação de monoamina | |
| PE20031011A1 (es) | Derivados de dihidrobenzodiazepin-2-ona-iii | |
| YU56301A (sh) | Inhibitori resorpcije monoamina za tretiranje poremećaja cns | |
| FI943247A0 (fi) | Piperatsiinijohdannaisia 5-HT-reseptoriantagonisteina | |
| PE20000467A1 (es) | Derivado de indol util como inhibidor de serotonina | |
| PE20020346A1 (es) | Derivados de fenoxibencilamina como ssri | |
| DE60014339D1 (de) | Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren | |
| PE20000127A1 (es) | Derivado de bencenosulfonamida | |
| DE60003899D1 (de) | Aryl-annellierte disubstituierte pyridine : nk3 rezeptor-liganden | |
| BR9908321A (pt) | Composto | |
| HRP20000508B1 (hr) | Supstituirani 2-benzilamino-2-fenil-acetamidni spojevi | |
| PE20021003A1 (es) | Fenil-heterociclil-eteres como inhibidores selectivos de la recaptacion de serotonina (ssri) | |
| ATE157977T1 (de) | Chinoxalinderivate als eaa antagonisten | |
| ES2182509T3 (es) | Derivados de n-ariloxietilamina para el tratamiento de la depresion. | |
| EA199900043A1 (ru) | ПРОИЗВОДНЫЕ ПИРИДИЛКАРБАМОИЛИНДОЛИНОВ В КАЧЕСТВЕ АНТАГОНИСТОВ 5-НТ2с-РЕЦЕПТОРОВ | |
| AR011542A1 (es) | Un procedimiento para la preparacion de derivados de benzofenona y un procedimiento para la preparacion de 3,4-dihidroxi-4'-metil-5-nitrobenzofenona. | |
| HUP0103358A2 (hu) | N-Szubsztituált aza-bicikloheptán-származékok, előállításuk és alkalmazásuk | |
| PT1140919E (pt) | Novos derivados de ciclohexano 1,4-dissubstituido para o tratamento da depressao | |
| AR009786A1 (es) | Pirrolcarboxamidas fusionadas, una nueva clase de ligandos receptores cerebrales gaba |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |